Table 3.
Univariate and multivariate analyses of OS in SCCE patients.
| Survival (%) | Chi-square | P value | HR (95% CI) | P value | |
|---|---|---|---|---|---|
| Age (years) | 0.686 | 0.408 | |||
| ≤60 | 16.7 | ||||
| >60 | 21.1 | ||||
| Gender | 1.841 | 0.175 | |||
| Female | 38.5 | ||||
| Male | 10.0 | ||||
| Tumor length (cm) | 6.846 | 0.009 | 0.627 | ||
| ≤3 | 33.3 | 1.000 | |||
| >3 | 8.0 | 1.229 (0.535–2.821) | |||
| Tumor location | 0.024 | 0.877 | |||
| Upper/middle | 20.0 | ||||
| Lower | 16.7 | ||||
| Vessel involvement | 1.068 | 0.301 | |||
| Negative | 21.2 | ||||
| Positive | 10.0 | ||||
| Depth of invasion | 7.433 | 0.006 | 0.103 | ||
| T1-2 | 33.3 | 1.000 | |||
| T3-4a | 8.0 | 2.032 (0.867–4.766) | |||
| Nodal metastasis | 9.687 | 0.002 | 0.092 | ||
| Negative | 40.0 | 1.000 | |||
| Positive | 7.1 | 2.182 (0.880–5.411) | |||
| Chemoradiotherapy | 5.577 | 0.018 | 0.011 | ||
| No | 5.9 | 1.000 | |||
| Yes | 26.9 | 0.380 (0.180–0.803) | |||
| NLR | 1.967 | 0.161 | |||
| <3.5 | 22.2 | ||||
| ≥3.5 | 12.5 | ||||
| PLR | 7.374 | 0.007 | 0.041 | ||
| <150 | 25.0 | 1.000 | |||
| ≥150 | 6.7 | 2.272 (1.035–4.984) |